Pyrazine diazohydroxide sodium
Pyrazine diazohydroxide (NSC 361456) sodium is an anti-tumor agent that forms DNA adducts via the reactive pyrazine diazonium ion. Pyrazine diazohydroxide sodium can be used for the study of renal cancer, colorectal cancer, melanoma and leukemia.
For research use only. We do not sell to patients.
- CAS No.: 103829-46-5
- Formula: C4H4N4NaO
- Molecular Weight:147.09
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All DNA/RNA Synthesis Isoforms
More
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Female nude mice (NCr-nu) were subcutaneously (s.c.) inoculated with 1 × 10⁶ LOX cells, resulting in spontaneous lung metastasis[1].
-
Dosage:44.5 mg/kg, 66.7 mg/kg, 150 mg/kg
-
Administration:I.p., once each on Day 12, 16, and 20
-
Result:Primary tumor: approximately 2.5 log10 Lung metastases: approximately 4.6 log10
Chemical Information
-
CAS No. 103829-46-5
-
Molecular Weight 147.09
-
Formula C4H4N4NaO
-
SMILES
O=NNC1=NC=CN=C1.[Na]
-
Synonyms
NSC-361456 sodium
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Harrison SD Jr, et al. Schedule dependence, activity against natural metastases, and cross-resistance of pyrazine diazohydroxide (sodium salt, NSC 361456) in preclinical models in vivo. Cancer Chemother Pharmacol. 1990;25(6):425-9. [Content Brief]
[2]. Vogelzang NJ, et al. Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer. Clin Cancer Res. 1998 Apr;4(4):929-34. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)